Skip to content

Understanding Your Medical Test: A Patient's Guide to Testing, Results, and What to Expect

Published: August 9, 2026Updated: August 17, 2026

A blood test to detect IgG antibodies against Rickettsia rickettsii, the bacterium that causes Rocky Mountain spotted fever.

Quick summary

{"This test checks if your immune system has produced antibodies against Rickettsia rickettsii bacteria","It helps diagnose Rocky Mountain spotted fever, a potentially serious tick-borne illness","IgG antibodies typically appear 7-10 days after infection","A positive result indicates past or current infection","Early treatment with antibiotics is crucial for best outcomes"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 17, 2026Editorial policy

Key facts at a glance

LOINC
110695-4
Short code
RICKG
Synonyms
R rickettsi IgG Msmt Ser
Category
cardiac
Sample
serum
Container
Serum separator tube (SST, gold top) or red top plain tube
Units
N/A
Ref low
25
Ref high
200
Critical range
— – 10000 N/A
Fasting
false
Population
adult
Sex
all
Age range
0–120 years
Method
Immunofluorescence Assay (IFA) or Enzyme-Linked Immunosorbent Assay (ELISA)
CPT
86757
SNOMED
78780007
Specimen volume
1.0-2.0 mL of serum minimum
Stability
Room temperature: 24-48 hours; Refrigerated (2-8°C): 5-7 days; Frozen (-20°C or below): 30 days or longer. Avoid repeated freeze-thaw cycles.
Hemolysis max
50
Lipemia max
300
Icterus max
20
TAT
48–168 hours
Order
routine

This test is a diagnostic procedure that your healthcare provider may order to gather important information about your health. It measures or evaluates specific substances, functions, or structures in your body, helping your care team assess how well your organs are working and whether an underlying condition may be present.

The Rickettsia rickettsii IgG antibody test is a blood test that detects immunoglobulin G (IgG) antibodies in your blood. These antibodies are produced by your immune system in response to infection with Rickettsia rickettsii, the bacterium that causes Rocky Mountain spotted fever (RMSF). This test helps determine whether you have been infected with this bacterium, either in the past or currently.

Your provider may recommend this test to help diagnose a medical condition, monitor an ongoing illness, evaluate how well a treatment is working, or screen for potential health problems before symptoms appear. The results give your care team objective information that guides decisions about your diagnosis, treatment options, and follow-up care.

This test is primarily ordered when a patient has symptoms suggestive of Rocky Mountain spotted fever, especially if they have been exposed to tick bites or live in areas where the disease is common. Symptoms of RMSF typically include fever, headache, rash (usually appearing 2-4 days after fever), and muscle pain. Since RMSF can progress rapidly and become severe or life-threatening if not treated early, this test helps healthcare providers confirm or rule out the infection.

How this test is performed depends on what your provider needs to evaluate. It may involve giving a small sample of blood, urine, or other body fluid, or it may use imaging technology or specialized equipment. A trained healthcare professional will carry out the procedure, explain each step, and tell you how to prepare, including whether you need to fast or avoid certain medications beforehand.

A healthcare professional will draw a small blood sample from a vein in your arm. The sample is then sent to a laboratory where it is analyzed to detect the presence of IgG antibodies against Rickettsia rickettsii. The test is typically performed using enzyme-linked immunosorbent assay (ELISA) or immunofluorescence assay (IFA) techniques.

Your results will show whether your values fall within the normal reference range for this test. Normal results generally suggest no evidence of the condition being checked for, while abnormal results may point to infection, inflammation, organ dysfunction, or another issue that needs attention. Your healthcare provider will review the findings with you, explain what they mean in the context of your overall health, and discuss any next steps, such as additional testing or starting treatment.

Results are generally reported as positive or negative. A positive result means that IgG antibodies against Rickettsia rickettsii were detected in your blood, indicating that you have been infected with the bacterium at some point. However, because IgG antibodies can persist in the blood for months or even years, a positive result does not necessarily mean you have an active infection. Your healthcare provider may need to interpret the results in conjunction with your symptoms, physical examination, and possibly additional tests (such as IgM antibody testing or PCR) to determine if you have a current infection.

For most patients, this test is safe and well tolerated. If a blood or tissue sample is collected, you may feel brief pain, notice minor bruising, or have slight bleeding at the needle site, and rarely an infection can develop. Tests involving imaging or other equipment may carry additional considerations, such as exposure to small amounts of radiation or an allergic reaction to contrast materials. Your healthcare team will explain the specific risks, and you should contact your provider if you notice unusual symptoms afterward.

The risks associated with this test are minimal and similar to those of any standard blood draw. These may include slight pain or bruising at the injection site, lightheadedness, or in rare cases, infection. The benefits of obtaining a accurate diagnosis far outweigh these minimal risks.

Reference range

NCBI: CK 25-200 U/LN/A

Specimen: serum

No special preparation required. Patient does not need to fast. Inform laboratory of recent travel history, tick exposure, or symptoms of Rocky Mountain spotted fever including fever, headache, rash, and myalgia.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

The Rickettsia rickettsii IgG antibody test is clinically significant for several reasons. First, it aids in the diagnosis of Rocky Mountain spotted fever, a disease caused by Rickettsia rickettsii transmitted through tick bites. Early diagnosis is critical because RMSF can progress rapidly and lead to severe complications including encephalitis, pneumonia, heart failure, and death if not treated promptly with appropriate antibiotics (typically doxycycline). Second, the test helps distinguish between past and current infections when combined with clinical findings, which guides treatment decisions. Third, it contributes to public health surveillance by helping authorities track the prevalence of this potentially serious tick-borne disease in different regions.

Frequently asked questions

How long does it take for IgG antibodies to appear after infection?
IgG antibodies against Rickettsia rickettsii typically begin to appear about 7-10 days after the initial infection. This is why early testing may be negative, and testing may need to be repeated if symptoms persist and there is strong clinical suspicion of RMSF.
Can this test tell if I have a current infection?
A single positive IgG test indicates exposure to the bacteria but cannot definitively distinguish between a current active infection and a past infection. Your healthcare provider may order additional tests such as IgM antibodies (which appear earlier and indicate more recent infection) or PCR testing (which detects the actual bacterium) to determine if the infection is active. They will also consider your symptoms and physical examination findings.
Do I need to fast before this test?
No, fasting is not required for this blood test. You can eat and drink normally before having your blood drawn.
How is Rocky Mountain spotted fever treated?
Rocky Mountain spotted fever is typically treated with doxycycline, an antibiotic that is most effective when started as early as possible in the course of the illness. Treatment usually continues for 7-10 days or until the patient has been afebrile for at least 48 hours. In severe cases, hospitalization and intravenous antibiotics may be necessary.
Where is Rocky Mountain spotted fever commonly found?
While historically associated with the Rocky Mountain region of the United States, RMSF is actually most commonly reported in the southeastern United States, including North Carolina, Tennessee, Missouri, Arkansas, and Oklahoma. It is also found in parts of South and Central America. The disease is transmitted by bites from infected American dog ticks, Rocky Mountain wood ticks, and brown dog ticks.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy